Saida, T., Yokoyama, K., Sato, R., Makioka, H., Iizuka, Y., Hase, M., . . . Torii, S. (2017). Safety and Effectiveness of Natalizumab: First Report of Interim Results of Post-Marketing Surveillance in Japan. Neurol Ther.
Citação norma ChicagoSaida, Takahiko, Kazumasa Yokoyama, Ryusuke Sato, Haruki Makioka, Yukihiko Iizuka, Masakazu Hase, Yan Ling, and Shinichi Torii. "Safety and Effectiveness of Natalizumab: First Report of Interim Results of Post-Marketing Surveillance in Japan." Neurol Ther 2017.
Citação norma MLASaida, Takahiko, et al. "Safety and Effectiveness of Natalizumab: First Report of Interim Results of Post-Marketing Surveillance in Japan." Neurol Ther 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.